John Wyand, the Life Science Industry Group leader for the Americas, is based in the Washington DC office. He is an experienced healthcare and life sciences lawyer who represents pharmaceutical companies, biotech companies and device manufacturers in a variety of FDA matters. He also represents hospitals and other direct-care providers in a wide range of strategic, regulatory and transactional matters. John is an M.B.A. with more than 20 years’ prior experience as a senior executive with a number of healthcare systems.
John advises clients engaged in cross-border medical services, patient mobility and medical travel programs, as well as financing healthcare infrastructure. John has experience advising clients in implementing Healthcare Reform initiatives such as accountable care organizations (ACOs), clinical co-management arrangements, clinically integrated networks, patient-centered medical homes, and joint ventures between hospitals and physicians.
John contributes to publications on healthcare compliance issues including fraud and abuse, and the Health Insurance Portability and Accountability Act (HIPAA) privacy and security regulations, as well as on the deployment and meaningful use of certified electronic health records.He is a Fellow of the American College of Healthcare Executives, a member of the American Bar Association and its Ehealth, Privacy & Security Committee, the American Health Lawyers Association and the District of Columbia Bar Association and its Health Law Section